Dr. Syed Anees Medicine Professional Corporation
Windsor, Ontario, Canada
Doctor in Windsor, Ontario
1720 Howard Ave, Windsor, ON N8X 5A6
About Dr. Syed Anees Medicine Professional Corporation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Boehringer Ingelheim
3
CSL Behring
1
Celgene
1
Clinical Trials at Dr. Syed Anees Medicine Professional Corporation
During the past decade, Dr. Syed Anees Medicine Professional Corporation conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
2013-04-25
2017-08-15
Completed
305
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
2017-07-26
2021-12-24
Completed
138
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
2017-12-25
2019-11-27
Completed
178
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
2020-07-28
2021-10-15
Completed
147
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-03-19
2023-02-10
Completed
665
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-08-30
2023-02-10
Terminated
117
CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
2022-01-27
2023-11-01
Recruiting
80
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
2022-09-19
2024-11-30
Recruiting
963
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dr. Syed Anees Medicine Professional Corporation
According to Clinical.Site data, the most researched conditions in "Dr. Syed Anees Medicine Professional Corporation" are
"Idiopathic Pulmonary Fibrosis" (8 trials), "Lung Diseases, Interstitial" (2 trials), "Fibrosis" (1 trials), "Idiopathic Interstitial Pneumonias" (1 trials) and "Interstitial Lung Disease" (1 trials). Many other conditions were trialed in "Dr. Syed Anees Medicine Professional Corporation" in a lesser frequency.
Clinical Trials Intervention Types at Dr. Syed Anees Medicine Professional Corporation
Most popular intervention types in "Dr. Syed Anees Medicine Professional Corporation" are "Drug" (7 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 1015550" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "6MWT" (1 trials) and "Accelerometry" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dr. Syed Anees Medicine Professional Corporation
The vast majority of trials in "Dr. Syed Anees Medicine Professional Corporation" are
9 trials for "All" genders.
Clinical Trials Status at Dr. Syed Anees Medicine Professional Corporation
Currently, there are NaN active trials in "Dr. Syed Anees Medicine Professional Corporation".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Dr. Syed Anees Medicine Professional Corporation,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dr. Syed Anees Medicine Professional Corporation, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".